ZERENEX E/5051404
![]() |
- $252 - $854.7
- Product name: ZERENEX E/5051404
- CAS: 445416-61-5
- MF: C22H22N4O4
- MW: 406.43
- EINECS:
- MDL Number:MFCD03270836
- Synonyms:ZERENEX E/5051404;2,2'-(2,2'-(Butane-1,4-diyl)bis(1H-benzo[d]-imidazole-2,1-diyl))diacetic acid;2,2'-[butane-1,4-diylbis(1H-benzimidazole-2,1-diyl)]diacetic acid;1H-Benzimidazole-1-acetic acid, 2,2'-(1,4-butanediyl)bis-
3 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500mg
- ManufacturerAK Scientific
- Product number3784AE
- Product description2,2'-(2,2'-(Butane-1,4-diyl)bis(1H-benzo[d]-imidazole-2,1-diyl))diaceticacid
- Packaging500mg
- Price$390
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0088913
- Product description2,2'-(2,2'-(BUTANE-1,4-DIYL)BIS(1H-BENZO[D]-IMIDAZOLE-2,1-DIYL))DIACETIC ACID 95.00%
- Packaging500MG
- Price$854.7
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number030700
- Product description2,2'-(2,2'-(Butane-1,4-diyl)bis(1H-benzo[d]-imidazole-2,1-diyl))diacetic acid
- Packaging500mg
- Price$252
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 3784AE | 2,2'-(2,2'-(Butane-1,4-diyl)bis(1H-benzo[d]-imidazole-2,1-diyl))diaceticacid | 500mg | $390 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0088913 | 2,2'-(2,2'-(BUTANE-1,4-DIYL)BIS(1H-BENZO[D]-IMIDAZOLE-2,1-DIYL))DIACETIC ACID 95.00% | 500MG | $854.7 | 2021-12-16 | Buy |
Matrix Scientific | 030700 | 2,2'-(2,2'-(Butane-1,4-diyl)bis(1H-benzo[d]-imidazole-2,1-diyl))diacetic acid | 500mg | $252 | 2021-12-16 | Buy |
Properties
Boiling point :753.0±55.0 °C(Predicted)
Density :1.38±0.1 g/cm3(Predicted)
pka :3.10±0.10(Predicted)
Density :1.38±0.1 g/cm3(Predicted)
pka :3.10±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|